Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 46th Annual Health Care Conference
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) FY 2026 Corporate Conference
Vertex Pharmaceuticals Incorporated (VRTX) Sec Form 10K
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Sec Form 10K
Vertex Pharmaceuticals Incorporated (VRTX) Sec Form 8K
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Sec Form 8K
Earnings
Vertex Pharma Q4 2025 Earnings Results
Vertex Pharmaceuticals reported solid financial results for the fourth quarter of 2025, driven by continued demand for its cystic fibrosis...
ADVERTISEMENT
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2025 Earnings Results
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2025 Earnings Release
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2025 Earnings Call
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2025 Earnings Conference
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2025 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q2 2025 Earnings Call dated Aug. 04, 2025 Corporate Participants: Susie Lisa — Senior Vice President, Investor Relations Reshma Kewalramani…
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2025 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2025 Earnings Call dated Nov. 03, 2025 Corporate Participants: Susie Lisa — Senior Vice President, Investor Relations Reshma Kewalramani…
ADVERTISEMENT
AlphaGraphs
Vertex Pharmaceuticals (VRTX) Earnings: 2Q23 Key Numbers
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported product revenue of $2.49 billion for the second quarter of 2023, which was up 14% year-over-year. Net income was $915.7…
Vertex Pharmaceuticals (VRTX) Earnings: 4Q22 Key Numbers
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2 billion in the same period…